A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis.
Johnston, Samantha C, Brenu, Ekua W, Hardcastle, Sharni L et al. · Health and quality of life outcomes · 2014 · DOI
Quick Summary
This study compared two different sets of criteria used to diagnose ME/CFS and looked at how severely the disease affected patients who met each definition. Researchers found that patients meeting the stricter International Consensus Criteria (ICC) definition had worse physical functioning, more pain, and greater disability than those who only met the older CDC criteria. This suggests that the ICC criteria identify a more severely affected group of patients within the broader ME/CFS population.
Why It Matters
Diagnostic criteria directly affect which patients receive an ME/CFS diagnosis and access to care. Understanding whether different criteria identify distinct patient subgroups with different severity levels helps clinicians better characterize disease presentations and may inform more precise patient stratification in future research and clinical practice.
Observed Findings
ICC-meeting patients had significantly lower SF-36 physical functioning scores compared to CDC-only patients.
ICC-meeting patients reported significantly greater disability across all WHO DAS 2.0 domains.
ICC-meeting patients had significantly lower scores for physical role limitations and bodily pain compared to CDC-only patients.
ICC-meeting patients showed significantly lower social functioning scores on the SF-36.
Inferred Conclusions
The ICC criteria identify a distinct, more severely affected subgroup within the broader population of patients meeting CDC criteria.
Physical and social functioning impairments are more pronounced in ICC-defined patients, suggesting different severity levels between diagnostic groups.
The choice of diagnostic criteria substantially impacts the clinical characteristics of identified patient populations.
Remaining Questions
Do ICC and CDC-defined patient groups differ in biological markers, disease mechanisms, or treatment response?
What proportion of ME/CFS patients meet ICC versus CDC criteria, and how does this vary across different populations and geographic regions?
Are there intermediate patient groups, and what symptom profiles best predict severity and functional impairment?
What This Study Does Not Prove
This pilot study does not prove that ICC criteria are superior or preferable to CDC criteria—it only shows they identify groups with different severity profiles. The small sample size and lack of biological marker measurements limit generalizability. The study cannot establish whether ICC patients are inherently different or whether the stricter criteria simply select for more severe cases within the same disease spectrum.
Tags
Symptom:PainFatigue
Method Flag:PEM Not DefinedSmall SampleExploratory Only